Adrenal Hyperandrogenism and Polycystic Ovary Syndrome

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|36|5588-5602

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.36, 2016-10, pp. : 5588-5602

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hirsutism Score and the Severity of Hyperandrogenism Associated with Polycystic Ovary Syndrome in the Southeastern Region of Turkey

By Demir B   Pasa S   Demir S   Tumer C   Atay AE   Gul T   Atamer Y  

The Journal of International Medical Research, Vol. 39, Iss. 4, 2011-07 ,pp. : 1529-1535

Field House Publishing

Access to resources Recommend Favorite

Polycystic ovary syndrome

By Franks Stephen  

Clinical Medicine, Vol. 32, Iss. 2, 1998-03 ,pp. : 111-113

Royal College Of Physicians

Access to resources Recommend Favorite

Advances in the treatment of polycystic ovary syndrome

By Moghetti Paolo  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 9, 2001-09 ,pp. : 1631-1640

Informa Healthcare

Access to resources Recommend Favorite

Metformin in the Treatment of Polycystic Ovary Syndrome

By  

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2121-2125

Bentham Science Publishers

Access to resources Recommend Favorite

Insulin Resistance and Polycystic Ovary Syndrome

By  

Current Pharmaceutical Design, Vol. 22, Iss. 36, 2016-11 ,pp. : 5526-5534

Bentham Science Publishers

Access to resources Recommend Favorite